Association of HIV, cardiovascular risk factors, and carotid intimal media thickness: A cross-sectional study in Western Kenya

• Published in: Medicine (Baltimore) 2022-11, Vol.101 (47), p.e31366-e31366
• Main Authors: Farrant, Maritza T., Masyuko, Sarah J., Kinuthia, John, Osoti, Alfred O., Mogaka, Jerusha N., Temu, Tecla M., Zifodya, Jerry S., Nakanjako, Damalie, Ameda, Faith, Farquhar, Carey, Page, Stephanie T.
• Format: Article
• Language: English
• Subjects: Adult; Cardiovascular Diseases - epidemiology; Cross-Sectional Studies; Female; Heart Disease Risk Factors; HIV Seropositivity; Humans; Hypercholesterolemia; Hypertension - complications; Hypertension - epidemiology; Kenya - epidemiology; Male; Middle Aged; Observational Study; Risk Factors
• ISSN: 1536-5964; 0025-7974; 1536-5964
• DOI: 10.1097/MD.0000000000031366

The carotid intimal media thickness (CIMT) is a validated measure of subclinical atherosclerosis. Human immunodeficiency virus (HIV) is a risk factor for cardiovascular disease (CVD) and has been associated with CIMT in North America and Europe; however, there are limited data from Sub-Saharan Africa (SSA). In this cross-sectional study, we measured CIMT in a cohort of 262 people living with HIV (PLHIV) on antiretroviral therapy (ART) for ≥6 months and HIV-negative adults in western Kenya. Using linear regression, we examined the associations between CVD risk factors and CIMT, both overall and stratified according to the HIV status. Among the PLHIV, we examined the association between CIMT and HIV-related factors. Of 262 participants, approximately half were women. The HIV-negative group had a higher prevalence of age ≥55 years ( P  = .002), previously diagnosed hypertension ( P  = .02), treatment for hypertension ( P  = .03), and elevated blood pressure (BP) ( P  = .01). Overall prevalence of carotid plaques was low (15/262 [6.0%]). HIV-positive status was not significantly associated with a greater mean CIMT ( P  = .19). In multivariable regression models, PLHIV with elevated blood pressure or treatment for hypertension had a greater mean CIMT ( P  = .002). However, the CD4 count, viral load, and ART regimen were not associated with differences in CIMT. In the HIV-negative group, older age ( P  = .006), high total cholesterol levels ( P  = .01), and diabetes ( P  = .02) were associated with a greater mean CIMT. In this cross-sectional study of Kenyan adults, traditional CVD risk factors were found to be more prevalent among HIV-negative participants. After multivariable regression analysis, we found no association between HIV status and CIMT, and PLHIV had fewer CVD risk factors associated with CIMT than HIV-negative participants did. HIV-specific factors were not associated with the CIMT.